• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Letter to the Editor
What is new in the 2024 Chinese guidelines for fatty liver disease?
Rui-Xu Yang1, Vincent Wai-Sun Wong2,3, Jian-Gao Fan1,4
1Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
3State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
4Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China
Correspondence :  Jian-Gao Fan ,
Tel: +86-21-25077340, Email: fanjiangao@xinhuamed.com.cn
Received: December 27, 2024  Revised: January 13, 2025   Accepted: January 18, 2025
KeyWords: Steatotic liver disease; obesity; metabolic syndrome; alcohol; China
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 537 View
  • 53 Download
Related articles

A new Korean nomenclature for steatotic liver disease2024 September;30(Suppl)

Waiting for the changes after the adoption of steatotic liver disease2023 October;29(4)

Risk factors in nonalcoholic fatty liver disease2023 February;29(Suppl)

Comparison between obese and non-obese nonalcoholic fatty liver disease2023 February;29(Suppl)

Personalized medicine in nonalcoholic fatty liver disease2022 October;28(4)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 284
TOTAL : 2773411
Close layer